Combination therapy for HIV-1 infection-overview: preclinical and clinical analysis of antiretroviral combinations
- 1 January 1996
- journal article
- research article
- Published by Elsevier in Antiviral Research
- Vol. 29 (1) , 35-39
- https://doi.org/10.1016/0166-3542(95)00912-4
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infectionNature, 1995
- Viral dynamics in human immunodeficiency virus type 1 infectionNature, 1995
- Multiple drug effect analysis with confidence intervalAntiviral Research, 1994
- Combination Therapy: More Effective Control of HIV Type 1?AIDS Research and Human Retroviruses, 1994
- Combination Therapy for Infection Due to Human Immunodeficiency Virus Type 1Clinical Infectious Diseases, 1994
- Resistance of clinical isolates of human immunodeficiency virus to antiretroviral agentsAntimicrobial Agents and Chemotherapy, 1993
- Strategic design and three-dimensional analysis of antiviral drug combinationsAntimicrobial Agents and Chemotherapy, 1993
- Human Immunodeficiency Virus Type 1 (HIV-1) Inhibitory Interactions between Protease Inhibitor Ro 31-8959 and Zidovudine, 2',3'-Dideoxycytidine, or Recombinant Interferon- A against Zidovudine-Sensitive or -Resistant HIV-1 In VitroThe Journal of Infectious Diseases, 1992
- BI-RG-587 is active against zidovudine-resistant human immunodeficiency virus type 1 and synergistic with zidovudineAntimicrobial Agents and Chemotherapy, 1991
- Three-Drug Synergistic Inhibition of HIV-l Replication In Vitro by Zidovudine, Recombinant Soluble CD4, and Recombinant Interferon-alpha AThe Journal of Infectious Diseases, 1990